NCT07008313

Brief Summary

The enhanced recovery after surgery(ERAS) has been gradually extended from its initial colorectal surgery to almost all surgical fields. However, there are few reports about the application value of ERAS in emergency surgery. The goal of this clinical trial is to evaluate the value of ERAS in the perioperative period of acute gastrointestinal perforation. All the patients will be treated by emergency operation. The changes of CRP, PA, PCT in Plasma 1 hour before operation and 1,3,7 days after operation, the operation time, the amount of bleeding during operation, the recovery time of intestinal function and the time of the first meal after operation,the incidence of postoperative complications, the degree of postoperative pain, the time of first out-of-bed activity, fatigue and mental status, quality of life, the length and the cost of hospital stay will be monitored and recorded.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
362

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2018

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

May 29, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 6, 2025

Completed
Last Updated

June 6, 2025

Status Verified

May 1, 2025

Enrollment Period

4.3 years

First QC Date

May 29, 2025

Last Update Submit

May 29, 2025

Conditions

Keywords

acute gastrointestinal perforationenhanced recovery after surgeryperioperative period

Outcome Measures

Primary Outcomes (3)

  • change of the c-reactive protein in plasma

    1, 3, and 7 days after surgery

  • change of the prealbumin in plasma

    1, 3, and 7 days after surgery

  • change of the procalcitonin in plasma

    1, 3, and 7 days after surgery

Study Arms (2)

the enhanced recovery after surgery (ERAS) group

EXPERIMENTAL

Patients were rehabilitated using the ERAS concept.

Behavioral: The enhanced recovery after surgery

the conventional surgical treatment (CST) group

PLACEBO COMPARATOR

Traditional treatment methods.

Behavioral: Traditional treatment methods.

Interventions

Enhanced recovery after surgery (ERAS) refers to a series of optimal management measures which are proved to be effective by evidence-based medical evidence in order to reduce patients' psychological and physiological traumatic stress reaction

the enhanced recovery after surgery (ERAS) group

Traditional treatment methods.

the conventional surgical treatment (CST) group

Eligibility Criteria

Age14 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age≥14years old and ≤80 years old
  • The initial diagnosis is acute gastrointestinal perforation

You may not qualify if:

  • Patients with unconsciousness,or patients with past psychiatric history
  • Patients with shock and/or severe organ failure
  • Patients who are pregnant
  • Patients with severe spinal deformity who are unable to receive epidural anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the Second Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 29, 2025

First Posted

June 6, 2025

Study Start

October 1, 2018

Primary Completion

January 1, 2023

Study Completion

January 31, 2023

Last Updated

June 6, 2025

Record last verified: 2025-05

Locations